Harvest Capital Strategies’s Phibro Animal Health PAHC Stock Holding History

Harvest Capital Strategies’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-80,000	Closed	-$2.96M	–	55
2017 Q2	$2.96M	Sell	80,000 -35,000	-30%	-$1.14M	0.35%	39
2017 Q1	$3.23M	Hold	115,000	–	–	0.32%	38
2016 Q4	$3.37M	Sell	115,000 -135,000	-54%	-$3.68M	0.46%	39
2016 Q3	$6.79M	Hold	250,000	–	–	0.99%	25
2016 Q2	$4.67M	Buy	250,000 +80,000	+47%	+$1.67M	0.65%	35
2016 Q1	$4.6M	Buy	170,000 +40,000	+31%	+$1.15M	0.54%	35
2015 Q4	$3.92M	Buy	130,000 +6,274	+5%	+$201K	0.54%	40
2015 Q3	$3.91M	Sell	123,726 -16,274	-12%	-$594K	0.7%	42
2015 Q2	$5.45M	Sell	140,000 -45,041	-24%	-$1.55M	0.7%	40
2015 Q1	$6.55M	Sell	185,041 -9,959	-5%	-$321K	0.58%	34
2014 Q4	$6.15M	Buy	195,000 +2,984	+2%	+$82.5K	0.69%	31
2014 Q3	$4.3M	Buy	192,016 +45,470	+31%	+$911K	0.35%	49
2014 Q2	$3.22M	Buy	+146,546	New	+$2.79M	0.17%	64

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FIM

Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return

VFA

Virtus Fund Advisers Hartford, Connecticut $32.1M AUM 39.5% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CRCP

Copper Rock Capital Partners Boston, Massachusetts $296M AUM 28.61% 1-Year Est. Return

DIA

Denver Investment Advisors Denver, Colorado $1.89B AUM 7.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Harvest Capital Strategies's PAHC Position: Q3 2017 in Review

Harvest Capital Strategies sold out of Phibro Animal Health (PAHC) in Q3 2017, closing a stake of 80,000 shares — an estimated $2.96M sold.

Harvest Capital Strategies first reported a position in PAHC in Q2 2014 and held it in 13 quarters. The position peaked at $6.79M in Q3 2016. 164 funds tracked by Wall St. Rank hold PAHC as of Q3 2017.

Harvest Capital Strategies reported no remaining Phibro Animal Health position as of Q3 2017 after selling out during the quarter.
Harvest Capital Strategies sold 80,000 Phibro Animal Health shares in Q3 2017, an estimated $2.96M.
Harvest Capital Strategies first reported a position in Phibro Animal Health in Q2 2014 and held it in 13 quarters.
Harvest Capital Strategies's Phibro Animal Health position peaked at $6.79M in Q3 2016.
164 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2017.

Based on Harvest Capital Strategies's 13F filing for Q3 2017, filed 14 Nov 2017.